IRVINE, Calif., April 19, 2017 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, ...
Please provide your email address to receive an email when new articles are posted on . Edwards Lifesciences announced the FDA clearance of its technology to monitor hemodynamics during PCI and other ...
Edwards Lifesciences Corporation, the global leader in patient-focused innovations for structural heart disease and critical care monitoring, has received CE Mark for its HemoSphere advanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback